Cryoprotectants for freeze drying of drug nano-suspensions: effect of freezing rate.

Drug nanoparticles are often prepared in a liquid medium, and a drying method such as freeze drying is used to convert them to an oral solid dosage form. When the dried form is reconstituted in an aqueous system, it may be redispersed to achieve its original particle size. The redispersibility of dried nanoparticles depends on the parameters of the freeze drying process. In this study, an apparatus with a freezing rate gradient was used to systematically investigate the effect of cryoprotectants on the redispersibility of nanoparticles as a function of freezing rate. Sucrose, lactose, mannitol, and polyethylene glycol were used as cryoprotectants for a naproxen nano-suspension. A fast freezing rate and a high cryoprotectant concentration were generally favored. However, under certain conditions, a slower freezing rate resulted in better redispersibility. This is probably because slow freezing can produce a more cryo-concentrated liquid phase, and the concentrated cryoprotectant in the liquid phase can more effectively protect the nanoparticles. An irreversible aggregation map was constructed as a function of the freezing rate and the cryoprotectant concentration, and shows both the favorable and unfavorable effects of cryoprotectants.

[1]  Carmen Popescu,et al.  Conversion of Nanosuspensions into Dry Powders by Spray Drying: A Case Study , 2008, Pharmaceutical Research.

[2]  A. Durand,et al.  Nanoparticles of hydrophobically modified dextrans as potential drug carrier systems. , 2007, Colloids and surfaces. B, Biointerfaces.

[3]  Filippos Kesisoglou,et al.  Nanosizing--oral formulation development and biopharmaceutical evaluation. , 2007, Advanced drug delivery reviews.

[4]  S. Stainmesse,et al.  Freeze-drying of nanoparticles: formulation, process and storage considerations. , 2006, Advanced drug delivery reviews.

[5]  J. Hirvonen,et al.  Freeze-drying of low molecular weight poly(L-lactic acid) nanoparticles: effect of cryo- and lyoprotectants. , 2006, Journal of nanoscience and nanotechnology.

[6]  Hatem Fessi,et al.  Investigation of nanocapsules stabilization by amorphous excipients during freeze-drying and storage. , 2006, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[7]  R. Thorne,et al.  Effects of cryoprotectant concentration and cooling rate on vitrification of aqueous solutions , 2006, physics/0604109.

[8]  Y. Cheng,et al.  Critical freezing rate in freeze drying nanocrystal dispersions. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[9]  R. Gref,et al.  Freeze-Drying of Composite Core-Shell Nanoparticles , 2006, Drug development and industrial pharmacy.

[10]  Samir Mitragotri,et al.  Prolonged circulation of large polymeric nanoparticles by non-covalent adsorption on erythrocytes. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[11]  Peter Harriott,et al.  Unit Operations of Chemical Engineering , 2004 .

[12]  Jonghwi Lee,et al.  Intrinsic adhesion force of lubricants to steel surface. , 2004, Journal of pharmaceutical sciences.

[13]  E. Merisko-Liversidge,et al.  Insulin Nanoparticles: A Novel Formulation Approach for Poorly Water Soluble Zn-Insulin , 2004, Pharmaceutical Research.

[14]  Helmut Schmidt,et al.  Stabilisation by freeze-drying of cationically modified silica nanoparticles for gene delivery. , 2003, International journal of pharmaceutics.

[15]  B. Raj,et al.  Three Distinct Scenarios under Polymer, Surfactant, and Colloidal Interaction , 2003 .

[16]  Jonghwi Lee Drug nano- and microparticles processed into solid dosage forms: physical properties. , 2003, Journal of pharmaceutical sciences.

[17]  R. Tilton,et al.  Coadsorption of Sodium Dodecyl Sulfate with Hydrophobically Modified Nonionic Cellulose Polymers. 1. Role of Polymer Hydrophobic Modification , 2003 .

[18]  R. Tilton,et al.  Coadsorption of Sodium Dodecyl Sulfate with Hydrophobically Modified Nonionic Cellulose Polymers. 2. Role of Surface Selectivity in Adsorption Hysteresis , 2003 .

[19]  Geoffrey Lee,et al.  Spray-freeze-drying for protein powder preparation: particle characterization and a case study with trypsinogen stability. , 2002, Journal of pharmaceutical sciences.

[20]  Robert Gurny,et al.  Preparation and characterization of sterile and freeze-dried sub-200 nm nanoparticles. , 2002, International journal of pharmaceutics.

[21]  J. Carpenter,et al.  The ice nucleation temperature determines the primary drying rate of lyophilization for samples frozen on a temperature-controlled shelf. , 2001, Journal of pharmaceutical sciences.

[22]  T. L. Hill A Different Approach to Nanothermodynamics , 2001 .

[23]  M. R. Aberturas,et al.  Freeze-drying of polycaprolactone and poly(D,L-lactic-glycolic) nanoparticles induce minor particle size changes affecting the oral pharmacokinetics of loaded drugs. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[24]  I. Bakaltcheva,et al.  Effects of high-molecular-weight cryoprotectants on platelets and the coagulation system. , 2000, Cryobiology.

[25]  R. Müller,et al.  Nanosuspensions of poorly soluble drugs--reproducibility of small scale production. , 2000, International journal of pharmaceutics.

[26]  A. Serajuddin,et al.  Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. , 1999, Journal of pharmaceutical sciences.

[27]  T. Imai,et al.  Effect of grinding with hydroxypropyl cellulose on the dissolution and particle size of a poorly water-soluble drug. , 1999, Chemical & pharmaceutical bulletin.

[28]  R. Bodmeier,et al.  Incorporation of polymeric nanoparticles into solid dosage forms. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[29]  A. Gomez,et al.  Production of protein nanoparticles by electrospray drying , 1998 .

[30]  J. M. Shaw,et al.  Formulation and Antitumor Activity Evaluation of Nanocrystalline Suspensions of Poorly Soluble Anticancer Drugs , 1996, Pharmaceutical Research.

[31]  G. Liversidge,et al.  Drug particle size reduction for decreasing gastric irritancy and enhancing absorption of naproxen in rats , 1995 .

[32]  G. Liversidge,et al.  Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs , 1995 .

[33]  J. Crison,et al.  A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability , 1995, Pharmaceutical Research.

[34]  J. Rosell-Llompart,et al.  Generation of monodisperse droplets 0.3 to 4 μm in diameter from electrified cone-jets of highly conducting and viscous liquids , 1994 .

[35]  S. C. Miller,et al.  Rheological properties of poloxamer vehicles , 1984 .

[36]  V. Torchilin,et al.  Drug targeting. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[37]  R. Gref,et al.  MPEO-PLA nanoparticles: effect of MPEO content on some of their surface properties. , 1999, Journal of biomedical materials research.

[38]  H Fessi,et al.  Influence of the stabilizer coating layer on the purification and freeze-drying of poly(D,L-lactic acid) nanoparticles prepared by an emulsion-diffusion technique. , 1998, Journal of microencapsulation.

[39]  H. Bosch,et al.  Sterile Filtration of NanoCrystal™ Drug Formulations , 1997 .

[40]  H. Ploehn,et al.  Interactions between colloidal particles and soluble polymers , 1990 .

[41]  Samuel Abraham Goldblith,et al.  Freeze-drying and advanced food technology. , 1975 .